Disclosed herein are compounds and methods of treating diseases and/or conditions associated with FGFR inhibition.
NOVEL COMPOUNDS
申请人:ALVARO Giuseppe
公开号:US20100144760A1
公开(公告)日:2010-06-10
Disclosed are N-[(1R,4S,6R)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals.